Development of CIRC Technologies
The Cleveland Clinic · NCT05654272
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 1000
- US sites recruiting
- 1
- Study start
- September 9, 2022
- Record last updated
- May 8, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Cardiovascular disease is the leading cause of death worldwide. Advanced cardiovascular imaging using Magnetic Resonance Imaging (MRI) has proven to be effective in providing gold standard myocardial tissue characterization. Moreover, the intrinsic advantage of MRI's lack of exposure to ionizing radiation is particularly beneficial. At the same time, blood work can be very useful in early detection of certain cardiomyopathy, such as amyloid. However, there is a lack of agreement of on which markers are the most sensitive. This multi-study will allow us the unique opportunity to form a more comprehensive understanding for various cardiovascular diseases.
Our team has developed novel cardiac MRI techniques that leverages endogenous tissue properties to reveal a milieu of deep tissue phenotypes including myocardial inflammation, fibrosis, metabolism, and microstructural defects. Among these phenotypes, myocardial microstructure has proven to be most sensitive to early myocardial tissue damage and is predictive of myocardial regeneration. In this study, the investigators aim to further study the importance of cardiac microstructure revealed by MRI in patient and healthy population and compare this novel technology with conventional clinical biomarkers.
Being studied: MRI
Conditions: Cardiovascular Diseases; Heart Failure; Ischemic Heart Disease; Non-ischemic Cardiomyopathy; Valvular Heart Disease; Metabolic Cardiomyopathy; Congenital Heart Disease; Aortic Diseases; Atrial Fibrillation; Ventricular Fibrillation
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Age ≥ 18 years of age
- Provision of written informed consent
- If not healthy volunteer, must be diagnosed with cardiovascular disease
Exclusion Criteria
- Vulnerable populations will be excluded from this study including Prisoners
- Other contraindications to CMR imaging to be determined by standard MRI protocols
- Decisionally impaired (e.g., dementia or cognitive disability)
Recruiting US locations
Cardiovascular Innovation Research Center
Cleveland, OH 44195
Site contact: Lily Chen · 216-445-8561 · chens7@ccf.org
Study contacts (from the official record)
- CIRC Program Coordinator · 216 636-5373 · circ@ccf.org
- CIRC Study Coordinator · chens7@ccf.org
Similar studies in Ohio
All heart & blood pressure studies in Ohio →- RecruitingHealthy volunteers
BoxX-NoAF Clinical Trial
AtriCure, Inc.
- Location
- Cincinnati, OH + 30 other US sites
- Eligibility basics
- Ages 65+
- Recruiting
Assessment of CCM in HF With Higher Ejection Fraction
Impulse Dynamics
- Location
- Cleveland, OH + 64 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
Pfizer
- Location
- Lima, OH + 27 other US sites
- Eligibility basics
- Ages 18–79
- Recruiting
Evaluation of the FARAFLEX Mapping and Pulsed Field Ablation System in Subjects With Atrial Fibrillation
Boston Scientific Corporation
- Location
- Columbus, OH + 9 other US sites
- Eligibility basics
- Ages 18+